Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele.

Current drug targets - 1 Feb 2011

Parmeggiani Francesco, Costagliola Ciro, Incorvaia Carlo, Sebastiani Adolfo, Gemmati Donato

Abstract excerpt

In Western Countries, the occurrence of choroidal neovascularization (CNV) secondary to different forms of macular degeneration represents a common cause of blindness. Particularly, age-related macular degeneration (AMD) and pathologic myopia (PM) are the most frequent diseases related to CNV development. At present, the combined employment of drugs acting against vascular endothelial growth factor (anti-VEGF)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Choroidal Neovascularization
Share to Fovea Centralis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myopia, Degenerative

Share to Photochemotherapy

Share to Photosensitizing Agents

Share to Porphyrins

Share to Vascular Endothelial Growth Factors

Share to Wet Macular Degeneration

Source

Identifiers

PMID: 20887247
DOI: 10.2174/138945011794182773

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele.PMID 20887247Read ↗

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.Semantic proximity Read ↗

Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration.Semantic proximity Read ↗

Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration.Semantic proximity Read ↗

Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia.Semantic proximity Read ↗

Genetic predictors of response to photodynamictherapy.Semantic proximity Read ↗

Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.Semantic proximity Read ↗

Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes.Semantic proximity Read ↗

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.Semantic proximity Read ↗

Polypoidal choroidal vasculopathy: clinical features and genetic predisposition.Semantic proximity Read ↗

The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients.Semantic proximity Read ↗

Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.